2020 ASCO Virtual Direct™ Highlights

 

2020 ASCO Virtual Direct™ Highlights
Avatar

2020 ASCO Updates on HER2-Expressing mCRC: Was There Any Activity in HER2+ Patients Treated With T-DXd ADC?

By 2020 ASCO Virtual Direct™ Highlights FEATURING Christina Gomez
By 2020 ASCO Virtual Direct™ Highlights FEATURING Christina Gomez
126 views
September 16, 2020
0 Comments
Login to view comments. Click here to Login

Featured Video

15:14
Icahn School of Medicine at Mount Sinai

Safety Profile of Ruxolitinib in Patients With MF

Feat. D. Tremblay

Featured Video

20:00
Exelixis

Child-Pugh Classification and its Role in Treatment Decisions in Pat…

Feat. P. Gholam
GI
07:15
2020 ASCO Virtual Direct™ Highlights

2020 ASCO Updates on Rectal & Esophageal Cancer: What Are the OP…

Feat. K. Mirabeau-Beale
36:52
2020 ASCO Virtual Direct™ Highlights

2020 ASCO Highlights on CRC: Pembro vs. Chemo for MSI-H/dMMR Metasta…

Feat. C. Gomez
08:49
2020 ASCO Virtual Direct™ Highlights

2020 ASCO Updates on mCRC: FDA Approved Encorafenib + Cetuximab Comb…

Feat. C. Gomez
07:19
2020 ASCO Virtual Direct™ Highlights

2020 ASCO Updates on HER2-Expressing mCRC: Was There Any Activity in…

Feat. C. Gomez
07:11
2020 ASCO Virtual Direct™ Highlights

2020 ASCO Highlights on Stage 3 Rectal Cancer: Can We Reduce Distant…

Feat. C. Gomez
19:57
2020 ASCO Virtual Direct™ Highlights

2020 ASCO Updates on GE Adenocarcinomas: How Does Neoadjuvant Trastu…

Feat. D. Catenacci
09:58
2020 ASCO Virtual Direct™ Highlights

Updates on Advanced GE Cancers: 2L FOLFIRI + Ramucirumab vs. Paclita…

Feat. D. Catenacci
05:59
2020 ASCO Virtual Direct™ Highlights

2020 ASCO Highlights on Pancreatic Cancer: Perioperative Chemo + mFO…

Feat. D. Catenacci